Management of heart failure in elderly people

M Imazio1, A Cotroneo, G Gaschino

  • 1Cardiology Department, Maria Vittoria Hospital, Torino, Italy. massimo_imazio@yahoo.it

Insights

Heart failure (HF) in elderly individuals presents unique challenges due to aging and comorbidities. Management often relies on empiric evidence from younger populations as older adults are typically excluded from clinical trials.

Area of Science:

  • Gerontology
  • Cardiology
  • Internal Medicine

Background:

  • Heart failure (HF) is a significant health concern in the elderly population.
  • Aging-related physiological changes can predispose individuals to HF and affect their response to illness.
  • Elderly patients often present with multiple chronic conditions and geriatric syndromes, complicating HF management.

Purpose of the Study:

  • To synthesize current knowledge on the presentation, clinical features, and management of heart failure in older adults.
  • To highlight the unique aspects of HF in the elderly and the challenges in its treatment.
  • To review the evidence base for HF management in elderly populations.

Main Methods:

  • A comprehensive literature search was conducted using multiple evidence-based databases.
  • Key databases included Cochrane Database of Systematic Reviews, Clinical Evidence, and MEDLINE.
  • Search terms focused on heart failure, elderly populations, and management strategies.

Main Results:

  • Aging features and comorbidities significantly impact HF presentation and progression in the elderly.
  • Diagnosis can be challenging due to atypical symptoms and overlapping conditions, though diagnostic criteria remain consistent.
  • Current drug treatments are largely empirical, mirroring recommendations for younger patients due to trial exclusions.
  • Disease management programs show promise in reducing HF morbidity and mortality in older adults.

Conclusions:

  • Heart failure is a leading cause of hospitalization and readmission among older adults.
  • HF in the elderly is characterized by specific features and frequent comorbidities, imposing a substantial global financial burden.
  • The exclusion of elderly individuals from clinical trials necessitates empirical management approaches based on data from younger cohorts.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...